• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Abbott Laboratories (NY: ABT )

    112.64 +0.41 (+0.37%)
    Official Closing Price Updated: 4:10 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,366,002
    Open 112.13
    Bid (Size) 111.86 (1)
    Ask (Size) 112.97 (1)
    Prev. Close 112.23
    Today's Range 111.68 - 112.75
    52wk Range 89.67 - 121.64
    Shares Outstanding 1,750,942,289
    Dividend Yield 1.81%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Magnificent Dividend Stocks to Buy in October
    These dividend stocks are great picks as the fall season gets underway. 
    Via The Motley Fool
    Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
    Investors can find market-trouncing blue chip stocks in the healthcare industry. 
    Via The Motley Fool

    Performance

    YTD
    +2.54%
    +2.54%
    1 Month
    -0.41%
    -0.41%
    3 Month
    +10.30%
    +10.30%
    6 Month
    +1.92%
    +1.92%
    1 Year
    +16.27%
    +16.27%

    More News

    Read More
    Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Down More Than 50%, Is DexCom Stock a Bargain Now?
    Via The Motley Fool
    2 Excellent Dividend Stocks to Buy With Less Than $200
    Via The Motley Fool
    Navigating 6 Analyst Ratings For Abbott Laboratories
    Via Benzinga
    Why ABBOTT LABORATORIES (NYSE:ABT) should be investigated by quality investors.
    Via Chartmill
    Looking Into Abbott Laboratories's Recent Short Interest
    Via Benzinga
    2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
    Via The Motley Fool
    Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
    Via Benzinga
    This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
    Via Benzinga
    20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns
    Via MarketBeat
    Topics Economy
    Exposures Economy Interest Rates
    Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
    Via The Motley Fool
    Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
    Via The Motley Fool
    3 Stocks to Buy and Hold Forever
    Via The Motley Fool
    3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold
    Via The Motley Fool
    2 Stocks That Are Passive Income Machines to Buy and Hold Forever
    Via The Motley Fool
    Medtronic Stock: Growth On Rise of the Cardiovascular Machines
    Via MarketBeat
    Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System
    Via Benzinga
    Topics Product Recall
    Exposures Legal Product Safety
    Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device
    Via Investor's Business Daily
    3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
    Via The Motley Fool
    Patchy But Still Bullish
    Via Talk Markets
    Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
    Via Benzinga
    Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.